| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 9,560 | 5,960 |
| Depreciation and amortization | 21,043 | 13,504 |
| Stock-based compensation expense | 6,832 | 4,652 |
| Distributions of earnings received from equity method investments | 0 | 0 |
| Income from equity method investments | 0 | 0 |
| Loss from debt investment | 0 | 0 |
| Gain on disposal of property and equipment | 2,528 | 3,004 |
| Amortization of deferred financing costs | 121 | 64 |
| Deferred income tax expense (benefit) | 2,729 | -1,961 |
| Accounts receivable, net | 670 | 1,638 |
| Inventory | 163 | 4 |
| Prepaid expenses and other assets | 626 | 150 |
| Trade payables | 767 | 1,598 |
| Deferred revenue | 622 | 499 |
| Accrued liabilities | 1,584 | -1,979 |
| Income tax payable/receivable | -5,796 | -2,433 |
| Net cash provided by operating activities | 33,475 | 15,108 |
| Purchase of property and equipment | 31,248 | 23,612 |
| Cash paid for acquisitions, net of cash acquired | 26,332 | 0 |
| Proceeds from sale of property and equipment | 15,026 | 13,355 |
| Net cash used in investing activities | -42,554 | -10,257 |
| Proceeds from exercise of options | 1,439 | 1,368 |
| Proceeds from term notes | 9,000 | - |
| Principal payments on term notes | 484 | 220 |
| Proceeds from revolving credit facilities | 13,000 | 0 |
| Payments on revolving credit facilities | 5,000 | - |
| Payments for debt issuance costs | 0 | 0 |
| Shares redeemed to pay income tax | 1,732 | 1,631 |
| Shares repurchased under the share repurchase program | 13,225 | 1,664 |
| Repayments of finance lease liabilities | 50 | 35 |
| Distributions to non-controlling interest | 286 | 193 |
| Net cash provided by (used in) financing activities | 2,662 | -2,375 |
| Net decrease in cash and cash equivalents | -6,417 | 2,476 |
| Cash and cash equivalents at beginning of period | 17,540 | - |
| Cash and cash equivalents at end of period | 11,123 | - |
VIEMED HEALTHCARE, INC. (VMD)
VIEMED HEALTHCARE, INC. (VMD)